#LCSM Chat Topic 4/10: “Exercise During and After Lung Cancer Treatment”
The next #LCSM Chat will occur Thursday April 10 at 8 PM EDT (5 PM PDT) and will focus on “Exercise During and After Lung Cancer Treatment.” Our moderator will be Janet Freeman-Daily. Exercise is known to improve quality of life and reduce recovery time, fatigue, sleep issues and depression in cancer patients. A recent study indicates high-intensity exercise during cancer treatment can have many benefits. Some facilities now offer pulmonary rehabilitation after lung cancer treatment to help patients recover lung capacity more quickly. Others offer fitness classes that adapt a fitness… Read More
Upcoming #LCSM Chat, Thursday, March 27 at 5 pm PT, 8 pm ET: Should All Targeted Rx Lung Cancer Trials be Biomarker-Selective?
ASCO, the American Society for Clinical Oncology, is promoting a new principle that targeted therapies should be used only in targeted patients, as part of a general trend that we need to move away from trials that test new non-chemotherapy agents in a broad population. Meanwhile, we’ve just recently seen a few high profile negative trials in the last few weeks, such as the large phase III METLung trial of “METMAb” or onartuzumab, the monoclonal antibody against the target MET (mesenchymal epithelial transition), combined with Tarceva (erlotinib), and also the MAGE-A3 vaccine… Read More
#LCSM Chat Preview March 13 – Stress, Anxiety and Lung Cancer: How Do You Cope?
Patients and caregivers experience considerable stress and anxiety as a result of lung cancer diagnosis and treatment. How do you handle stress? Is it possible to prevent stress or is it ‘just a part of life’? Some individuals handle stress and anxiety better than others. We want to explore this topic in more detail during this week’s #LCSM chat. T1: What kinds of stress do lung cancer patients experience due to their cancer diagnosis or treatment? T2: What can healthcare providers do to help reduce stress for a lung cancer patient or caregiver?… Read More
You must be logged in to post a comment.